Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

55.20
Delayed Data
As of 4:00pm ET
 +1.05 / +1.94%
Today’s Change
33.30
Today|||52-Week Range
59.05
+38.52%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close54.15
Today’s open54.05
Day’s range53.70 - 55.25
Volume643,870
Average volume (3 months)706,734
Market cap$3.0B
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)-38.64%
Earnings growth (this year)+79.76%
Earnings growth (next 5 years)+40.60%
Revenue growth (last year)+40.57%
P/E ratio40.0
Price/Sales7.03
Price/Book10.96

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.42+2.88%
HZNPHorizon Pharma PLC+0.18+1.03%
FOLDAmicus Therapeutics ...+0.31+1.88%
AXONAxovant Sciences Ltd-0.52-15.20%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)$0.46
Annual revenue (last year)$302.2M
Annual profit (last year)$57.3M
Net profit margin18.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts